Clozapine Treatment Reverses Dizocilpine-induced Deficits of Pre-pulse Inhibition of Tactile Startle Response

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2007 Mar 16

PMID 17355891

Citations 10

Authors

Edward D Levin

D Patrick Caldwell

Charles Perraut

Affiliations

Soon will be listed here.

Abstract

Pre-pulse inhibition (PPI) is a phenomenon of neurobehavioral plasticity in which the motor response to a startling sensory stimulus is inhibited by a preceding sensory stimulus of a lower intensity. The current experiment used tactile startle rather than acoustic startle to determine the generality of PPI across sensory modalities. PPI is easily modeled in experimental animals and serves as a useful method for determining the neural bases for sensorimotor plasticity, which can be disturbed in sensory modulation disorders. In the current study, female Sprague-Dawley rats were tested for tactile startle PPI after an auditory pre-pulse. The glutamate NMDA receptor antagonist dizocilpine (MK-801, 0.05 mg/kg) caused a nearly total blockade of the PPI effect (p<0.0005). The antipsychotic drug clozapine (1.25 mg/kg, p<0.001 and 2.5 mg/kg p<0.05) significantly attenuated the dizocilpine-induced PPI impairment. Interestingly, the lower clozapine dose did not by self enhance PPI and the higher clozapine dose when given alone caused a significant (p<0.05) PPI impairment relative to control. Nicotine (0.2 and 0.4 mg/kg) did not significantly interact with the other treatments, though the higher nicotine dose did show a trend toward attenuating the PPI impairment caused by the high clozapine dose. These effects were replicated in a second experiment of clozapine-dizocilpine interactions without nicotine treatment. This study shows that PPI of tactile startle is dramatically impaired by blocking NMDA activation and that the prototypic atypical antipsychotic drug clozapine can correct this deficit. This may be relevant to the action of clozapine in attenuating sensory gating deficits in schizophrenia and may point to new avenues of treatment for sensory modulation disorders in which there is excessive tactile response.

Citing Articles

Editorial: Sensory Processing Across the Lifespan: A 25-Year Initiative to Understand Neurophysiology, Behaviors, and Treatment Effectiveness for Sensory Processing.

Miller L, Marco E, Chu R, Camarata S Front Integr Neurosci. 2021; 15:652218.

PMID: 33897385 PMC: 8063042. DOI: 10.3389/fnint.2021.652218.

Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms.

Khoja S, Asatryan L, Jakowec M, Davies D Front Cell Neurosci. 2019; 13:331.

PMID: 31396053 PMC: 6664007. DOI: 10.3389/fncel.2019.00331.

Brainstem reflexes are hyperactive in patients with drug-induced akathisia.

Metin B, Metin S, Gunduz A, Poyraz B, Ozmen M, Kiziltan G Neurol Sci. 2017; 38(9):1683-1689.

PMID: 28681310 DOI: 10.1007/s10072-017-3038-y.

Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.

Oliveras I, Sanchez-Gonzalez A, Sampedro-Viana D, Piludu M, Rio-Alamos C, Giorgi O Psychopharmacology (Berl). 2017; 234(6):957-975.

PMID: 28154892 PMC: 5492384. DOI: 10.1007/s00213-017-4534-8.

Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.

Callahan P, Terry Jr A, Tehim A Psychopharmacology (Berl). 2014; 231(18):3695-706.

PMID: 24595504 PMC: 4748388. DOI: 10.1007/s00213-014-3509-2.

References

Depoortere R, Perrault G, Sanger D . Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex. Behav Pharmacol. 2000; 10(1):51-62. DOI: 10.1097/00008877-199902000-00005. View

Lipina T, Labrie V, Weiner I, Roder J . Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology (Berl). 2005; 179(1):54-67. DOI: 10.1007/s00213-005-2210-x. View

Geyer M, Braff D, Swerdlow N . Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001; 156(2-3):117-54. DOI: 10.1007/s002130100811. View

Braff D, Geyer M, Swerdlow N . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001; 156(2-3):234-58. DOI: 10.1007/s002130100810. View

Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F . Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Psychopharmacology (Berl). 2002; 159(1):105-10. DOI: 10.1007/s002130100905. View

Seeman P . Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002; 47(1):27-38. View

Le Pen G, Moreau J . Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002; 27(1):1-11. DOI: 10.1016/S0893-133X(01)00383-9. View

Kumari V, Sharma T . Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl). 2002; 162(2):97-101. DOI: 10.1007/s00213-002-1099-x. View

Oranje B, van Oel C, Gispen-de Wied C, Verbaten M, Kahn R . Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol. 2002; 22(4):359-65. DOI: 10.1097/00004714-200208000-00005. View

10.

Linn G, Negi S, Gerum S, Javitt D . Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology (Berl). 2003; 169(3-4):234-9. DOI: 10.1007/s00213-003-1533-8. View

11.

Hughes J, Hatsukami D, Mitchell J, Dahlgren L . Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986; 143(8):993-7. DOI: 10.1176/ajp.143.8.993. View

12.

Mansbach R, Geyer M . Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 1989; 2(4):299-308. DOI: 10.1016/0893-133x(89)90035-3. View

13.

Keith V, Mansbach R, Geyer M . Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry. 1991; 30(6):557-66. DOI: 10.1016/0006-3223(91)90025-h. View

14.

Swerdlow N, Geyer M . Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 1993; 44(3):741-4. DOI: 10.1016/0091-3057(93)90193-w. View

15.

SCHOTTE A, Janssen P, Megens A, Leysen J . Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 1993; 631(2):191-202. DOI: 10.1016/0006-8993(93)91535-z. View

16.

Bakshi V, Swerdlow N, Geyer M . Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 1994; 271(2):787-94. View

17.

Acri J, Morse D, Popke E, Grunberg N . Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology (Berl). 1994; 114(2):369-74. DOI: 10.1007/BF02244861. View

18.

Hoffman D, Donovan H, Cassella J . The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology (Berl). 1993; 111(3):339-44. DOI: 10.1007/BF02244950. View

19.

Swerdlow N, Bakshi V, Geyer M . Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 1996; 279(3):1290-9. View

20.

Swerdlow N, Varty G, Geyer M . Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat?. Neuropsychopharmacology. 1997; 18(1):50-6. DOI: 10.1016/S0893-133X(97)00110-3. View